Bright Minds Biosciences Financial Overview
Bright Minds Biosciences's market cap is currently C$365.53M. The company's EPS TTM is $-0.53699062; its P/E ratio is -54.19; Bright Minds Biosciences is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.57. See an overview of income statement, balance sheet, and cash flow financials.
